Metabolic dysfunction‐associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiethnic urban population in Malaysia-Reference-Cited by-同舟云学术

Metabolic dysfunction‐associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiethnic urban population in Malaysia

Published:2022-07-12 Issue:2 Volume:36 Page:107-116
ISSN:0894-0959
Container-title:Seminars in Dialysis
language:en
Short-container-title:Seminars in Dialysis

Author:

Wong Wei‐Kei¹^ORCID,Chan Wah‐Kheong²^ORCID,Ganapathy Shubash Shander³^ORCID,Lim Soo‐Kun⁴^ORCID

Affiliation:

1. Department of Medicine University of Malaya, Faculty of Medicine Kuala Lumpur Malaysia

2. Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine University of Malaya Kuala Lumpur Malaysia

3. National Institutes of Health Ministry of Health Malaysia

4. Nephrology Unit, Department of Medicine, Faculty of Medicine University of Malaya Kuala Lumpur Malaysia

Publisher

Wiley

Subject

Nephrology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/sdi.13117

Reference35 articles.

1. Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment

2. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

3. A qualitative examination of barriers and solutions to renal transplantation in Malaysia: Key-informants’ perspective

4. GoddardE Estimating Alcohol Consumption from Survey Data: Updated Method of Converting Volumes to Units. In National Statistics Methodology Series No.37. Newport RI 2007.

5. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association